|
MechanismProstaglandin synthases inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Neurorecovery, Inc.
0 Patents (Medical) associated with Neurorecovery, Inc.
100 Deals associated with Neurorecovery, Inc.
100 Translational Medicine associated with Neurorecovery, Inc.